Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Diabetes
|
December 1, 1993
Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice
E W Heineke, M B Johnson, J E Dillberger, et al.
Archives of Biochemistry and Biophysics
|
May 1, 1985
Mechanism responsible for the hypoglycemic action of 2-alkoxy-2-propenylidene methanaminiums
R A Harris, G A Cook, R D McDermott, et al.
Bulletin of Environmental Contamination and Toxicology
|
February 1, 1979
Lethal and reproductive effects of dietary mirex and DDT on old-field mice, Peromyscus polionotus
J L Wolfe, R J Esher, K M Robinson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1985
Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism
K M Robinson, A J Payne, S L Zehr, et al.
Biochemical Pharmacology
|
May 15, 1990
Castanospermine-glucosides as selective disaccharidase inhibitors
B L Rhinehart, K M Robinson, C H King, et al.
Metabolism: Clinical and Experimental
|
February 1, 1994
MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein
M J Sheetz, R L Barnhart, R L Jackson, et al.
Scanning Electron Microscopy
|
January 1, 1980
Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro
L Maistry, K M Robinson, P Evers, et al.
Journal of the National Cancer Institute
|
June 1, 1986
Human esophageal carcinoma cell lines: prostaglandin production, biological properties, and behavior in nude mice
J H Botha, K M Robinson, N Ramchurren, et al.
Acta Neurologica Scandinavica
|
October 1, 1995
Sentence comprehension in multiple sclerosis
M Grossman, K M Robinson, K Onishi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1989
Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors
K M Robinson, B L Rhinehart, M E Begovic, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Diabetes
|
December 1, 1993
Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice
E W Heineke, M B Johnson, J E Dillberger, et al.
Archives of Biochemistry and Biophysics
|
May 1, 1985
Mechanism responsible for the hypoglycemic action of 2-alkoxy-2-propenylidene methanaminiums
R A Harris, G A Cook, R D McDermott, et al.
Bulletin of Environmental Contamination and Toxicology
|
February 1, 1979
Lethal and reproductive effects of dietary mirex and DDT on old-field mice, Peromyscus polionotus
J L Wolfe, R J Esher, K M Robinson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1985
Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism
K M Robinson, A J Payne, S L Zehr, et al.
Biochemical Pharmacology
|
May 15, 1990
Castanospermine-glucosides as selective disaccharidase inhibitors
B L Rhinehart, K M Robinson, C H King, et al.
Metabolism: Clinical and Experimental
|
February 1, 1994
MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein
M J Sheetz, R L Barnhart, R L Jackson, et al.
Scanning Electron Microscopy
|
January 1, 1980
Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro
L Maistry, K M Robinson, P Evers, et al.
Journal of the National Cancer Institute
|
June 1, 1986
Human esophageal carcinoma cell lines: prostaglandin production, biological properties, and behavior in nude mice
J H Botha, K M Robinson, N Ramchurren, et al.
Acta Neurologica Scandinavica
|
October 1, 1995
Sentence comprehension in multiple sclerosis
M Grossman, K M Robinson, K Onishi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1989
Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors
K M Robinson, B L Rhinehart, M E Begovic, et al.
Page
of 9